Abcam plc

US ABCZF

22.25USD
-(-%)

Last update at 2025-05-22T13:30:00Z

Day Range

22.2522.25
LowHigh

52 Week Range

22.2522.25
LowHigh

Fundamentals

  • Previous Close 22.25
  • Market Cap5120.86M
  • Volume0
  • P/E Ratio2225.00
  • Dividend Yield-%
  • EBITDA106.00M
  • Revenue TTM379.70M
  • Revenue Per Share TTM1.66
  • Gross Profit TTM 270.50M
  • Diluted EPS TTM0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-12-31 2022-06-30 2021-12-31 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-12-31 2022-06-30 2021-12-31 2021-06-30
Income before tax -15.60000M -15.60000M 4.70M 4.70M 25.40M
Minority interest - - - - -
Net income -8.50000M -8.50000M 4.40M 4.40M 16.20M
Selling general administrative 224.50M 224.50M 189.70M 189.70M 147.40M
Selling and marketing expenses 224.50M 224.50M 189.70M 189.70M -
Gross profit 270.50M 270.50M 224.60M 224.60M 211.80M
Reconciled depreciation 52.90M 52.90M 41.00M 41.00M 35.40M
Ebit -10.20000M -10.20000M 6.40M 6.40M 33.60M
Ebitda 42.70M 42.70M 47.40M 47.40M 64.00M
Depreciation and amortization 52.90M 52.90M 41.00M 41.00M -
Non operating income net other - - - - -
Operating income -10.10000M -10.10000M 7.10M 6.40M 36.50M
Other operating expenses 371.80M 371.80M 308.30M 308.30M -
Interest expense 5.40M 5.50M 1.70M 1.70M 3.20M
Tax provision -7.10000M -7.10000M 0.30M 0.30M 9.20M
Interest income 0.40M 0.40M 0.30M 0.30M 0.40M
Net interest income -5.50000M -5.50000M -2.40000M -2.40000M -2.80000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -7.10000M -7.10000M 0.30M 0.30M 5.60M
Total revenue 361.70M 361.70M 315.40M 315.40M 297.70M
Total operating expenses 280.60M 283.30M 217.50M 217.50M 261.20M
Cost of revenue 91.20M 91.20M 90.80M 90.80M 85.90M
Total other income expense net -5.50000M -5.50000M -2.40000M -1.70000M -8.90000M
Discontinued operations - - - - -
Net income from continuing ops -8.50000M -8.50000M 4.40M 4.40M 16.20M
Net income applicable to common shares -8.50000M -8.50000M 4.40M 4.40M 25.60M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-12-31 2022-06-30 2021-12-31 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-12-31 2022-06-30 2021-12-31 2021-06-30
Total assets 1056.60M 1056.60M 986.10M 986.10M -
Intangible assets 227.90M 227.90M 234.20M 234.20M -
Earning assets - - - - -
Other current assets 8.10M 31.40M 0.50M 58.20M 0.30M
Total liab 329.70M 329.70M 330.00M 330.00M -
Total stockholder equity 726.90M 726.90M 656.10M 656.10M -
Deferred long term liab - - - - -
Other current liab 50.60M 50.90M 45.90M 38.50M 10.10M
Common stock 0.50M 0.50M 0.50M 0.50M 0.50M
Capital stock 0.50M 0.50M 0.50M 0.50M -
Retained earnings 300.70M 300.70M 289.60M 289.60M 271.70M
Other liab 32.10M 32.10M 41.50M 41.50M 27.60M
Good will 398.30M 398.30M 364.80M 364.80M -
Other assets 12.10M 12.10M 10.40M 10.40M 15.60M
Cash 89.00M 89.00M 95.10M 95.10M -
Cash and equivalents - - - - -
Total current liabilities 201.80M 201.80M 187.20M 187.20M 52.00M
Current deferred revenue 7.30M 7.30M - - -
Net debt 134.90M 134.90M 134.60M 134.60M -
Short term debt 128.10M 128.10M 128.40M 128.40M -
Short long term debt 119.60M 119.60M 119.20M 119.20M -
Short long term debt total 223.90M 223.90M 229.70M 229.70M -
Other stockholder equity 267.50M 267.50M 366.00M 366.00M 94.20M
Property plant equipment 159.70M 159.70M 161.70M 161.70M 157.30M
Total current assets 255.40M 255.40M 211.50M 211.50M 306.20M
Long term investments 3.20M 3.20M - - -
Net tangible assets 100.70M 100.70M 57.10M 57.10M 293.00M
Short term investments - - - - -
Net receivables 90.30M 67.00M 52.60M 33.20M 40.40M
Long term debt - - - - -
Inventory 68.00M 68.00M 58.20M 58.20M 42.90M
Accounts payable 15.80M 15.80M 12.90M 12.90M 13.80M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 158.20M 158.20M - 99.90M -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - 3.50M 3.50M -
Deferred long term asset charges - - - - -
Non current assets total 801.20M 801.20M 774.60M 774.60M -
Capital lease obligations 104.30M 104.30M 110.50M 110.50M -
Long term debt total - - - - -
Breakdown 2023-06-30 2022-12-31 2022-06-30 2021-12-31 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-12-31 2022-06-30 2021-12-31 2021-06-30
Investments -24.40000M -24.40000M -0.10000M -0.10000M -0.10000M
Change to liabilities -6.20000M -6.20000M 6.20M 6.20M 7.20M
Total cashflows from investing activities -24.40000M -24.40000M -291.50000M -291.50000M -44.40000M
Net borrowings -11.30000M -11.30000M 111.20M 111.20M -221.60000M
Total cash from financing activities -15.50000M -15.50000M 111.40M 111.40M 30.00M
Change to operating activities - - - - -
Net income -10.10000M -10.10000M 7.10M 4.40M 25.60M
Change in cash -6.10000M -6.10000M -116.80000M -116.80000M 49.20M
Begin period cash flow 95.10M 95.10M 211.90M 211.90M 187.30M
End period cash flow 89.00M 89.00M 95.10M 95.10M 219.90M
Total cash from operating activities 28.70M 28.70M 62.90M 62.90M 66.60M
Issuance of capital stock 1.10M 1.10M 3.20M 3.20M 127.40M
Depreciation 52.90M 52.90M 41.00M 41.00M 35.40M
Other cashflows from investing activities 0.70M 0.70M 13.50M 13.50M 4.60M
Dividends paid 0.00000M 0.00000M - - -
Change to inventory -7.40000M -7.40000M -6.20000M -6.20000M -7.00000M
Change to account receivables -33.30000M -33.30000M 4.00M 4.00M -15.40000M
Sale purchase of stock -0.20000M -0.20000M 0.00000M -0.10000M -0.10000M
Other cashflows from financing activities -5.10000M -5.10000M 108.20M 111.40M -2.20000M
Change to netincome 31.20M 31.20M 13.50M 13.50M 24.20M
Capital expenditures 41.30M 41.30M 59.80M 59.80M 23.00M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -46.90000M -46.90000M 4.00M 4.00M -0.30000M
Stock based compensation 23.30M 23.30M 17.90M 17.90M 13.60M
Other non cash items 9.50M 9.50M -7.10000M -4.40000M -1.40000M
Free cash flow -12.60000M -12.60000M 3.10M 3.10M 14.70M

Peer Comparison

Sector: Industry:

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ABCZF
Abcam plc
- -% 22.25 2225.00 32.57 13.49 5.67 11.07 67.57
TBB
AT&T Inc
-0.06 0.27% 21.81 4.60 - - -
STMZF
Scottish Mortgage Investment Trust PLC
- -% 13.19 - - 2.56 -
SHZHY
Shenzhou International Group Holdings Limited
-0.0002 0.0028% 7.05 24.80 14.99 0.63 3.21 0.51 1.99
ELPQF
El Puerto de Liverpool S.A.B. de C.V
- -% 4.78 11.85 12.59 0.05 1.07 0.05 0.26

Reports Covered

Stock Research & News

Profile

Abcam Limited, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company's principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, biochemicals, and cell signaling pathway tools. It serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. The company has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. It sells its products online. Abcam Limited was formerly known as Abcam plc and changed its name to Abcam Limited in December 2023. The company was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom. As of December 6, 2023, Abcam Limited operates as a subsidiary of Danaher Corporation.

Abcam plc

Discovery Drive, Cambridge, United Kingdom, CB2 0AX

Key Executives

Name Title Year Born
Mr. Alan Thomas Hirzel BS, M.B.A., M.S., MBA, MS CEO & Exec. Director 1968
Mr. Michael Shaun Baldock B.A. CFO & Director 1964
Mr. Mark Dermody Interim CIO NA
James Staveley VP of Investor Relations NA
Marc Perkins Gen. Counsel & Company Sec. NA
Emma Sceats Sr. VP of Sales, Service & Bus. Devel. NA
Mr. Nick Skinner Sr. VP of HR NA
Mr. Mark Bushfield Sr. VP of Research & Innovation NA
Ms. Kirstie Speck BBusSc Head of Consumer Insights NA
Ms. Yvonne Chien Sr. VP of Customer Experience NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.